Affordable Access

Publisher Website

Lymphocytes and neutrophils as peripheral models to study the effect of β-amyloid on cellular calcium signalling in Alzheimer's disease

Life Sciences
Publication Date
DOI: 10.1016/0024-3205(96)00329-3
  • Alzheimer'S Disease
  • Free Intracellular Calcium
  • Lymphocytes
  • Neutrophils
  • Potassium Channels
  • Membrane Fluidity
  • β-Amyloid
  • Biology
  • Medicine


Abstract According to the calcium hypothesis of brain aging, disturbances of free intracellular calcium homeostasis ([Ca 2+] i) play a key role in pathology of Alzheimer's disease (AD). Recent data from neuronal tissue culture support the contribution of the β-amyloid peptide (βA) to neurodegeneration in AD, probably by disruption of the intracellular Ca 2+ regulation. On the basis of this premise, we used peripheral blood cells to examine the role of βA on Ca 2+ signalling, not only to obtain an experimental approach to investigate these effects of βA in man, but also to search for AD-specific alterations of the effects of βA on Ca 2+ signalling. This approach is based on observations indicating that the phytohemagglutinin (PHA)-induced Ca 2+ response in circulating human lymphocytes of healthy volunteers is affected by βA and its fragment 25–35 in a fashion similar to its effects on central neurons, whereas we found no effect of βA on receptor-activated Ca 2+ response in neutrophils. Therefore, we used human blood lymphocytes as peripheral model systems to search directly for AD-related abnormalities of Ca 2+ regulation, for alterations of βA effects on Ca 2+ signalling and on membrane fluidity, and for possible changes of potassium channels. In accordance with our data in neutrophils, we were unable to identify any relevant change of the PHA-induced Ca 2+ elevations in lymphocytes, which is not supporting the assumption of general alterations of cellular Ca 2+ regulation in AD. On the other hand, the amplifying effect of βA on Ca 2+ signalling was significantly reduced in lymphocytes from AD patients. Moreover, Ca 2+ responses to βA25–35 were not different between early- and late-onset AD patients. Our findings indicate that the sensitivity of the lymphocyte for the effects of βA is reduced in a high percentage of patients with probable or possible AD. As possible explanation we observed a similar reduction of the sensitivity of the lymphocyte membrane for the fluidity-decreasing properties of βA. Finally, the inhibition of the PHA-induced Ca 2+ response by tetraethylammonium (TEA) was lower in the AD group compared to aged controls. This could suggest the presence of a K + channel dysfunction on AD lymphocytes, as it has been shown on skin fibroblasts of AD patients.

There are no comments yet on this publication. Be the first to share your thoughts.